US Stock MarketDetailed Quotes

IVVD Invivyd

Watchlist
  • 0.444
  • +0.014+3.30%
Close Dec 20 16:00 ET
  • 0.430
  • -0.014-3.11%
Post 20:01 ET
53.10MMarket Cap-0.23P/E (TTM)

About Invivyd Company

Invivyd, Inc.(formerly Adagio Therapeutics, Inc.) engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.

Company Profile

SymbolIVVD
Company NameInvivyd
Listing DateAug 6, 2021
Founded2020
CEOMr. William Duke, Jr
MarketNASDAQ
Employees95
Fiscal Year Ends12-31
Address1601 Trapelo Road,Suite 178
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-819-0080
Websitehttp://invivyd.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert Allen
  • Chief Scientific Officer
  • --
  • William Duke, Jr
  • Principal Executive Officer, Chief Financial Officer and Principal Accounting Officer
  • --
  • Julie Green
  • Chief Human Resources Officer
  • --
  • Timothy Lee
  • Chief Commercial Officer
  • --
  • Stacy Price
  • Chief Technology and Manufacturing Officer
  • --
  • Jill Andersen
  • Chief Legal Officer and Corporate Secretary
  • 2.08M
  • Marc Elia
  • Chairman of the Board
  • 138.63K
  • Tan Berry
  • Director
  • 93.13K
  • Terrance G. Mcguire
  • Independent Director
  • 97.13K
  • Kevin F. Mclaughlin
  • Independent Director
  • --
  • Srishti Gupta
  • Independent Director
  • --
  • Christine Lindenboom
  • Independent Director
  • 80.44K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List